Ann: Cynata Extends FUJIFILM Licence Option in GvHD, page-246

Thanks for this pfeifer.
wainwright forcast MSB at $17.Which is either good news for MSB shareholders or means the Wainwright analsyt couldnt find his way back to ths bigtop!!

As uv brought up the past..lets not forget Celularity.

the simple positives are... in the absence of a clear commercial road path forward;

OA..15 mill...prof Hunter

directors loans ( belief in the future)

outstanding trials.

a number of phase 2

Prof Rasco..Li Ka,Shing gene and cell therapy centre..?

cymerus research making it into highlevel symposiums.


But..we need other stuff now...the commercial near misses have gone on too long now and the lack of validity is down to only one thing.!

comfortably we should be $4 plus now!!!!

if not higher!